Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 11 - 20 of 184 items for :

  • "neuroendocrine carcinoma" x
  • Refine by access: All content x
Clear All
O Hentic Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by O Hentic in
Google Scholar
PubMed Close
,
P Hammel Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by P Hammel in
Google Scholar
PubMed Close
,
A Couvelard Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by A Couvelard in
Google Scholar
PubMed Close
,
V Rebours Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by V Rebours in
Google Scholar
PubMed Close
,
M Zappa Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by M Zappa in
Google Scholar
PubMed Close
,
M Palazzo Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by M Palazzo in
Google Scholar
PubMed Close
,
F Maire Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by F Maire in
Google Scholar
PubMed Close
,
G Goujon Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by G Goujon in
Google Scholar
PubMed Close
,
A Gillet Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by A Gillet in
Google Scholar
PubMed Close
,
P Lévy Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by P Lévy in
Google Scholar
PubMed Close
, and
P Ruszniewski Pôle des Maladies de L'appareil Digestif, Service de Pathologie, Service de Radiologie, Service de Gastroentérologie–Pancréatologie

Search for other papers by P Ruszniewski in
Google Scholar
PubMed Close

condition due to aggressive and diffuse disease. These tumors are characterized by aggressive histological features (high Ki-67 index, extensive necrosis, and nuclear atypia) and are classified as neuroendocrine carcinomas (NECs) grade 3 according to the new

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-12-0002
Volume/Issue:
Volume 19: Issue 6
Free access
Andreas Venizelos K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Andreas Venizelos in
Google Scholar
PubMed Close
,
Hege Elvebakken Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

Search for other papers by Hege Elvebakken in
Google Scholar
PubMed Close
,
Aurel Perren Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed Close
,
Oleksii Nikolaienko K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Oleksii Nikolaienko in
Google Scholar
PubMed Close
,
Wei Deng K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Wei Deng in
Google Scholar
PubMed Close
,
Inger Marie B Lothe Department of Pathology, Oslo University Hospital, Oslo, Norway

Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed Close
,
Anne Couvelard Department of Pathology, Université de Paris, Bichat Hospital, AP-HP, Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed Close
,
Geir Olav Hjortland Department of Oncology, Oslo University Hospital, Oslo, Norway

Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed Close
,
Anna Sundlöv Departmentt of Oncology, Skåne University Hospital, Lund, Sweden
Department of Medical Radiation Physics, Lund University, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed Close
,
Johanna Svensson Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Johanna Svensson in
Google Scholar
PubMed Close
,
Harrish Garresori Department of Oncology, Stavanger University Hospital, Stavanger, Norway

Search for other papers by Harrish Garresori in
Google Scholar
PubMed Close
,
Christian Kersten Department of Research, Hospital of Southern Norway, Kristiansand, Norway

Search for other papers by Christian Kersten in
Google Scholar
PubMed Close
,
Eva Hofsli Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Department of Oncology, St.Olavs Hospital, Trondheim, Norway

Search for other papers by Eva Hofsli in
Google Scholar
PubMed Close
,
Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark
Department of Clinical Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed Close
,
Merete Krogh Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Merete Krogh in
Google Scholar
PubMed Close
,
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close
, and
Stian Knappskog K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Stian Knappskog in
Google Scholar
PubMed Close

-differentiated neuroendocrine tumours (NET G3) and poorly differentiated neuroendocrine carcinoma (NEC) ( WHO 2019 ). GEP-NEC have a particularly unfavourable prognosis, with median overall survival <1 year in advanced, treated cases and only 1 month if untreated ( Sorbye et

Article Type:
Research Article
Collections:
Top-cited articles of 2023
DOI:
https://doi.org/10.1530/ERC-21-0152
Volume/Issue:
Volume 29: Issue 1
Open access
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Sciences, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close
,
Grace Kong Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia

Search for other papers by Grace Kong in
Google Scholar
PubMed Close
, and
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed Close

of their proliferation index (G1–G3), whereas neuroendocrine carcinoma (NEC) category is used for poorly differentiated neoplasms. The high-grade GEP NEN G3 group (Ki-67 >20%) is therefore now separated into two groups: NET G3 and NEC ( Table 1 ) and

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-19-0400
Volume/Issue:
Volume 27: Issue 3
Free access
Jessica L Geiger Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute, Division of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Pittsburgh Medical Center, Division of Molecular Genomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, 5150 Centre Avenue, 5th Floor, Pittsburgh, Pennsylvania, 15232, USA

Search for other papers by Jessica L Geiger in
Google Scholar
PubMed Close
,
Simion I Chiosea Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute, Division of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Pittsburgh Medical Center, Division of Molecular Genomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, 5150 Centre Avenue, 5th Floor, Pittsburgh, Pennsylvania, 15232, USA

Search for other papers by Simion I Chiosea in
Google Scholar
PubMed Close
,
Sue M Challinor Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute, Division of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Pittsburgh Medical Center, Division of Molecular Genomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, 5150 Centre Avenue, 5th Floor, Pittsburgh, Pennsylvania, 15232, USA

Search for other papers by Sue M Challinor in
Google Scholar
PubMed Close
,
Marina N Nikiforova Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute, Division of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Pittsburgh Medical Center, Division of Molecular Genomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, 5150 Centre Avenue, 5th Floor, Pittsburgh, Pennsylvania, 15232, USA

Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed Close
, and
Julie E Bauman Division of Hematology/Oncology, Department of Internal Medicine, University of Pittsburgh Cancer Institute, Division of Anatomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Pittsburgh Medical Center, Division of Molecular Genomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, 5150 Centre Avenue, 5th Floor, Pittsburgh, Pennsylvania, 15232, USA

Search for other papers by Julie E Bauman in
Google Scholar
PubMed Close

). Tumor formation occurs in the neuroendocrine organs where constitutively activated RET is expressed. Although neuroendocrine carcinoma (NEC) of the lung has been described in MEN 1 ( Farhandi et al . 1987 ), it has not been described in the MEN2

Article Type:
Editorial
DOI:
https://doi.org/10.1530/ERC-15-0307
Volume/Issue:
Volume 22: Issue 5
Free access
Esben Andreas Carlsen Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark
Department of Biomedical Sciences, Cluster for Molecular Imaging, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Esben Andreas Carlsen in
Google Scholar
PubMed Close
,
Nicola Fazio Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for other papers by Nicola Fazio in
Google Scholar
PubMed Close
,
Dan Granberg Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Dan Granberg in
Google Scholar
PubMed Close
,
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, Department of Endocrinology & Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed Close
,
Hojjat Ahmadzadehfar Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany

Search for other papers by Hojjat Ahmadzadehfar in
Google Scholar
PubMed Close
,
Chiara Maria Grana Division of Nuclear Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for other papers by Chiara Maria Grana in
Google Scholar
PubMed Close
,
Wouter T Zandee Erasmus Medical Center, Rotterdam, The Netherlands

Search for other papers by Wouter T Zandee in
Google Scholar
PubMed Close
,
Jaroslaw Cwikla Medical School, University of Warmia and Mazury, Olsztyn, Poland

Search for other papers by Jaroslaw Cwikla in
Google Scholar
PubMed Close
,
Martin A Walter Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland

Search for other papers by Martin A Walter in
Google Scholar
PubMed Close
,
Peter Sandor Oturai Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen, Denmark

Search for other papers by Peter Sandor Oturai in
Google Scholar
PubMed Close
,
Anja Rinke Department of Gastroenterology, University Hospital Gießen and Marburg, Marburg, Germany

Search for other papers by Anja Rinke in
Google Scholar
PubMed Close
,
Andrew Weaver Department of Oncology, Churchill Hospital, Oxford, UK

Search for other papers by Andrew Weaver in
Google Scholar
PubMed Close
,
Andrea Frilling Department of Surgery and Cancer, Imperial College London, London, UK

Search for other papers by Andrea Frilling in
Google Scholar
PubMed Close
,
Sara Gritti Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy

Search for other papers by Sara Gritti in
Google Scholar
PubMed Close
,
Anne Kirstine Arveschoug Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anne Kirstine Arveschoug in
Google Scholar
PubMed Close
,
Amichay Meirovitz Department of Oncology and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Amichay Meirovitz in
Google Scholar
PubMed Close
,
Ulrich Knigge Department of Biomedical Sciences, Cluster for Molecular Imaging, University of Copenhagen, Copenhagen, Denmark
Departments of Surgical Gastroenterology and Clinical Endocrinology, Rigshospitalet, Copenhagen, Denmark

Search for other papers by Ulrich Knigge in
Google Scholar
PubMed Close
, and
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed Close

according to the proliferation index Ki-67; ≤2% (Grade 1, G1), 3–20% (G2) and >20% (G3) ( Bosman et al . 2010 ). G1–G2 was collectively referred to as neuroendocrine tumors (NET) and G3 as neuroendocrine carcinoma (NEC). The classification is strongly

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-18-0424
Volume/Issue:
Volume 26: Issue 2
Free access
Thomas Yang Sun Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

Search for other papers by Thomas Yang Sun in
Google Scholar
PubMed Close
,
Lan Zhao Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

Search for other papers by Lan Zhao in
Google Scholar
PubMed Close
,
Paul Van Hummelen Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

Search for other papers by Paul Van Hummelen in
Google Scholar
PubMed Close
,
Brock Martin Department of Pathology, Stanford University School of Medicine, Stanford, California, USA

Search for other papers by Brock Martin in
Google Scholar
PubMed Close
,
Kathleen Hornbacker Clinical Trials Office, Stanford University, Stanford, California, USA

Search for other papers by Kathleen Hornbacker in
Google Scholar
PubMed Close
,
HoJoon Lee Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

Search for other papers by HoJoon Lee in
Google Scholar
PubMed Close
,
Li C Xia Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
Division of Biostatistics, Department of Epidemiology and Public Health, Albert Einstein College of Medicine, Bronx, New York, USA

Search for other papers by Li C Xia in
Google Scholar
PubMed Close
,
Sukhmani K Padda Cedars-Sinai Medical Center, Department of Medical Oncology, Los Angeles, California, USA

Search for other papers by Sukhmani K Padda in
Google Scholar
PubMed Close
,
Hanlee P Ji Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
Stanford Genome Technology Center, Stanford, California, USA

Search for other papers by Hanlee P Ji in
Google Scholar
PubMed Close
, and
Pamela Kunz Yale School of Medicine, Smilow Cancer Hospital, Yale Cancer Center, New Haven, Connecticut, USA

Search for other papers by Pamela Kunz in
Google Scholar
PubMed Close

-differentiated G3 NET and poorly differentiated neuroendocrine carcinoma in the most recent version of the WHO classification system, NENs from other primary sites have not been similarly categorized ( Klimstra 2019 ). For example, the recent 2021 WHO

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0015
Volume/Issue:
Volume 29: Issue 12
Restricted access
Lisa D Berman-Booty Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA

Search for other papers by Lisa D Berman-Booty in
Google Scholar
PubMed Close
and
Karen E Knudsen Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA
Department of Cancer Biology, Kimmel Cancer Center, Departments of Urology, Radiation Oncology, Thomas Jefferson University, 233 South 10th Street, BLSB 1008, Philadelphia, Pennsylvania 19107, USA

Search for other papers by Karen E Knudsen in
Google Scholar
PubMed Close

Introduction Prostate cancer is the second most common cancer in men worldwide ( Ferlay et al . 2010 ). With >90% of prostate cancers initially diagnosed as acinar adenocarcinomas ( Fine 2012 , Humphrey 2012 ), neuroendocrine carcinomas of the

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-14-0393
Volume/Issue:
Volume 22: Issue 1
Free access
Maria Chiara Zatelli Department of Medical Sciences, Section of Endocrinology and Internal Medicine, University of Ferrara, Ferrara, Italy

Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed Close
,
Elia Guadagno Department of Advanced Biomedical Sciences, Pathology Section, University of Naples Federico II, Naples, Italy

Search for other papers by Elia Guadagno in
Google Scholar
PubMed Close
,
Erika Messina Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

Search for other papers by Erika Messina in
Google Scholar
PubMed Close
,
Fabio Lo Calzo Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

Search for other papers by Fabio Lo Calzo in
Google Scholar
PubMed Close
,
Antongiulio Faggiano Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed Close
,
Annamaria Colao Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

Search for other papers by Annamaria Colao in
Google Scholar
PubMed Close
, and
NIKE Group
Search for other papers by NIKE Group in
Google Scholar
PubMed Close

considers neuroendocrine carcinomas (NECs) as a single category on the basis of a Ki-67 labeling index (LI) >20% ( Rindi et al. 2010 ). It has recently become apparent that the definition of NEC by the 2010 WHO classification includes a spectrum of

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-17-0507
Volume/Issue:
Volume 25: Issue 6
Free access
A Mohamed Division of Hematology and Medical Oncology, UH Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA

Search for other papers by A Mohamed in
Google Scholar
PubMed Close
,
M Trybula Division of Hematology and Medical Oncology, UH Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA

Search for other papers by M Trybula in
Google Scholar
PubMed Close
,
S L Asa Department of Medicine, UH Seidman Cancer Center Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA

Search for other papers by S L Asa in
Google Scholar
PubMed Close
,
T R Halfdanarson Division of Medical Oncology, Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA

Search for other papers by T R Halfdanarson in
Google Scholar
PubMed Close
, and
M B Sonbol Division of Hematology and Medical Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona, USA

Search for other papers by M B Sonbol in
Google Scholar
PubMed Close

classification, delineating G3-NETs as a distinct category from the poorly differentiated neuroendocrine carcinoma (NEC) ( Table 1 ) ( Velayoudom-Cephise et al. 2013 , Heetfeld et al. 2015 , Nagtegaal et al. 2020 , Elvebakken et al. 2021 , Luecke et

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-24-0025
Volume/Issue:
Volume 31: Issue 10
Restricted access
Günter Klöppel Department of Pathology, Technical University of München, Ismaninger Strasse 22, 81675 München, Germany

Search for other papers by Günter Klöppel in
Google Scholar
PubMed Close

differentiated endocrine carcinoma/small cell carcinoma (PDEC) 2. Neuroendocrine carcinoma (NEC) G3 large cell or small cell type 4. Mixed exocrine–endocrine carcinoma (MEEC) 3. Mixed adenoneuroendocrine carcinoma (MANEC) II. Pseudotumour lesions 5. Tumour

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-11-0013
Volume/Issue:
Volume 18: Issue S1
Free access